The ABMTRR has collected data on paediatric stem cell transplants since 1992. It is important the data focussed on paediatric bone marrow failure is collated and analysed to show activity and outcomes, and to then compare against international standards. This will determine best future practice to improve outcomes for patients.
This project aims to publish the transplant outcomes from the ABMTRR for Severe Aplastic Anaemia and other Bone Marrow Failure Syndromes in Australia and New Zealand in a high impact international journal so that local performance can be benchmarked against other international publications and registry data to establish an ANZ guideline for future management of these patients who come to transplant and make recommendations regarding indications for transplant.
2016 – 2019 (Grant-in-Aid) Identification of microRNA biomarkers predictive of clinical outcomes in Aplastic Anaemia and Myelodysplastic Syndrome, Dr Lynette Chee, Melbourne Health. DNA is the genetic material which provides the information that ...
Read more2021-2024 (Grant-in-Aid): Precision gene editing for the treatment of Fanconi Anaemia. Dr Lorna McLeman, St Vincent’s Institute of Medical Research. Fanconi Anaemia is the most common cause of inherited bone marrow failure with a median onset of ...
Read more2018-2021 (Grant-in-Aid): Identifying therapeutics which can be repurposed for the treatment of Myelodysplastic Syndromes and other bone marrow failure disorders. Associate Professor Amee George, The Australian National University. There are ...
Read more2018-2020 (Grant in aid): Discovering new genes and mutations that cause failure of bone marrow neutrophil production. Professor Graham Lieschke, Australian Regenerative Medicine Institute/Monash University and The Royal Melbourne Hospital. ...
Read more